Quick Answer
LifeStance Health Group, Inc. reported Common Stock Shares Outstanding of 388.32 million shares for the year ending 2025.
- LifeStance Health Group, Inc. showed an increase of +1.5% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from LifeStance Health Group, Inc.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2021: 374.15 million shares | Q3 2021: 374.15 million shares | Q1 2022: 374.32 million shares | Q2 2022: 376.18 million shares | Q3 2022: 376.04 million shares | Q1 2023: 376.54 million shares | Q2 2023: 378.01 million shares | Q3 2023: 378.61 million shares | Q1 2024: 382.11 million shares | Q2 2024: 383.31 million shares | Q3 2024: 382.64 million shares | Q1 2025: 388.83 million shares | Q2 2025: 389.08 million shares | Q3 2025: 389.00 million shares.
- Historical annual values: Fiscal year 2025: 388.32 million shares | Fiscal year 2024: 382.74 million shares | Fiscal year 2023: 378.73 million shares | Fiscal year 2022: 375.96 million shares | Fiscal year 2021: 374.26 million shares | Fiscal year 2020: 0 shares.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: